Tirzepatide, a dual GIP GLP 1 receptor co agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Cardiovascular Diabetology Springer Nature Link Glucagon Like Peptide 1 Based Therapies: A New Horizon in Obesity Management Switching from Semaglutide to Tirzepatide: Is It a Good Idea? Hubmed New pharmacological treatments for obesity: incretin analogues, their mechanism of action, efficacy and safety Medicine Today PDF] Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial. Semantic Scholar How to Know When to Increase Your GLP1 Dose and When to Add Supportiv Revolution Health & Wellness